Mirion Tech

Q2 FY2026 EarningsQ2 FY26 revenue reached $266.8M, up 19.7% YoY, primarily driven by the Nuclear & Safety segment which grew 31.4% to $186.2M following key acquisitions (Paragon and Certrec). Medical revenue was flat at $80.6M (-0.7% YoY) due to APAC headwinds and dosimetry softness. Gross margin improved to 49.9% (+390bps) through positive mix, while net income attributable to the company slightly declined to $7.7M from $8.3M YoY, impacted by a $1.0M foreign currency loss vs a $13.5M gain in the prior year.